For journalists & researchers · Data study · CC-BY-4.0

Reader Survey 2026 — Press Kit

Reporter and researcher resources for the ClearHormones Reader Survey 2026, an open, reader-contributed study of how women navigate US hormonal-health telehealth. This kit is embargo-safe: it publishes methodology and dataset-access terms now, and no result figures until the sample is large enough to report responsibly.

The story, in one paragraph

ClearHormones is fielding an original reader survey on the real friction women hit when they shop for hormonal-health telehealth: what they are trying to solve, the biggest barrier to access, what monthly price they consider reasonable, how they expect to pay, and how much upfront pricing transparency drives which provider they choose. It is an open, opt-in, anonymous instrument with no free-text fields and no personal data collected. Aggregated results and the full dataset publish under Creative Commons Attribution 4.0 (CC-BY-4.0) once the sample reaches 200 responses, so any figure a reporter quotes is drawn from a sample large enough to stand behind. Until that gate is reached, this kit shares the instrument and methodology but no numbers.

Key facts

Every value below is live or verifiable. No result percentages appear here while collection is in progress.

Study
ClearHormones Reader Survey 2026: Hormonal Telehealth Access & Pricing
Publisher
ClearHormones Editorial
Instrument
6 fixed single-select questions, no free text
Fielding since
2026-07-02
Responses so far
0 collected
Publication gate
200 responses (200 to go)
Results status
Embargoed until threshold reached
License
CC-BY-4.0 (attribution required, commercial reuse permitted)
Live page
https://clearhormones.com/research/reader-survey-2026

Response count updates daily and is read directly from the live database. It is deliberately the only number on this page: shares and rankings do not exist yet because the sample has not reached the publication threshold.

Methodology & instrument

This is an open, self-selected online survey. Respondents are readers who reach the survey page and opt in, so the sample is a signal from an engaged, hormonal-health-interested audience, not a probability sample of the US population. We state that limitation plainly rather than dressing the results up as representative. Every question is a fixed single-select item with no free-text field, so responses carry no personal information; we collect no name, email, or health record. Submissions are rate-limited and honeypot-protected against automated spam, and aggregated percentages are withheld until at least 200 responses are collected.

The full methodology and question wording live on the survey page: Reader Survey 2026 methodology.

What the survey measures

  1. What is the primary reason you are researching hormonal-health telehealth?
    Options: Menopause or perimenopause symptoms · Access to hormone replacement therapy (HRT) · GLP-1 medication or weight management · PCOS management · General hormonal health · Just exploring my options
  2. What has been the biggest barrier you have faced so far?
    Options: Cost or monthly price · Finding a provider licensed in my state · Providers not accepting my insurance · Knowing which provider to trust · Understanding my treatment options · No major barrier so far
  3. What monthly out-of-pocket price would you consider reasonable?
    Options: Under $50 / month · $50 to $100 / month · $100 to $200 / month · $200 to $400 / month · Over $400 / month · Not sure yet
  4. How do you expect to pay for care?
    Options: Cash / out of pocket · HSA or FSA · Insurance · Not sure yet
  5. How important is upfront pricing transparency when choosing a provider?
    Options: Critical — I skip providers who hide prices · Important, but not a dealbreaker · Somewhat important · Not important to me
  6. Where are you in your journey right now?
    Options: Just starting to research · Comparing providers · Ready to sign up · Currently a telehealth patient · Have switched providers at least once

Get the dataset

On publication we release an aggregate dataset (CSV and JSON) alongside the on-page results, both under CC-BY-4.0. The release contains per-question option counts and shares only, never raw per-response rows, so it carries no personal or re-identifiable data. Reporters and researchers who want the aggregate files the moment the threshold is reached can request the embargoed dataset in advance, and we will send it the day it publishes.

  • To request early/embargoed access: email [email protected] with your outlet and deadline. We reply within one business day.
  • What you receive on publication: aggregate CSV, aggregate JSON, the methodology, and the canonical page URL for citation.
  • Attribution: credit “ClearHormones Reader Survey 2026: Hormonal Telehealth Access & Pricing” with a link back to the canonical page. Any figure or chart may be republished under CC-BY-4.0.

APA citation

ClearHormones. (2026). ClearHormones Reader Survey 2026: Hormonal Telehealth Access & Pricing. Retrieved 2026-07-02 from https://clearhormones.com/research/reader-survey-2026

BibTeX

@techreport{clearhormones_reader_survey_2026,
  title  = {ClearHormones Reader Survey 2026: Hormonal Telehealth Access & Pricing},
  author = {{ClearHormones Editorial}},
  year   = {2026},
  url    = {https://clearhormones.com/research/reader-survey-2026},
  note   = {Open reader survey. Licensed CC-BY-4.0}
}

Embargo note

The results embargo is keyed to sample size, not a calendar date. It lifts automatically the moment the survey reaches 200 responses, at which point aggregated counts and shares publish on the survey page and the dataset files are released. Please do not publish, quote, or characterize any result figures before the gate lifts; there are no preliminary percentages to report while collection is in progress. If you need a heads-up the day the threshold is reached, ask to be added to the notify list at the contact below.

Media contact

Press inquiries & interviews: [email protected]
Dataset requests & corrections: [email protected]
Attribution desk: ClearHormones Editorial
Response SLA: within one business day for press requests

We route all inquiries through the ClearHormones editorial desk. We do not publish under a placeholder spokesperson name; interviews are attributed to the editorial desk unless a named, credentialed reviewer is engaged and disclosed.

Back to the live study: Reader Survey 2026 · General newsroom resources: ClearHormones press kit